Unity Biotechnology, Inc (UBX): Expected earnings per share growth for next year
Analyzing the forward-looking net income dynamics on GURU.Markets, we see that the latest figure for Unity Biotechnology (UBX) is 7.90. These metrics are driven by the search for unique niches in senescence therapy with high pricing power, although current demand is limited by the clinical trial stage. In the future, clearing the body of senescent cells will provide Unity Biotechnology (UBX) with long-term revenue through patent protection.
unitybiotechnology.com - analytical breakdowns and key metrics (UBX)
- price and consensus price forecast:
- stock exchange capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Total Debt to Capital Unity Biotechnology|UBX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Unity Biotechnology, Inc.|UBX - Company Aggregate Debt|Debt to Book Capitalization Ratio Unity Biotechnology|UBX - Long-Term Debt|Company Short-Term Debt Unity Biotechnology|Quick Liquidity unitybiotechnology.com
- earnings and valuation multiples information:
UBX - Company Net Income|Projected Future Earnings Unity Biotechnology|UBX - Market Cap to Net Income Ratio|Projected Price to Earnings Unity Biotechnology|UBX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Unity Biotechnology|UBX - Operating profit EBITDA|Net earnings per share (EPS TTM) Unity Biotechnology|UBX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months unitybiotechnology.com|UBX - Earnings per share growth this year|Earnings growth forecast for next year Unity Biotechnology
General company analysis:UBX, Unity Bio
This metric measures the percentage change in expected net earnings per share, reflecting the analysts' consensus forecast for future business profitability. For Unity Biotechnology (UBX), the forward net income growth rate depends critically on the efficiency of R&D spending on senolytics, as high development costs coupled with a liquidity shortage make any earnings expectations extremely volatile.
Competitors of Unity Biotechnology
Net earnings per share growth forecast for next year Tempus AI, Inc|Expected net earnings per share growth next year Qiagen Corp QGEN|Expected earnings per share growth for next year IONS (Ionis Pharmaceuticals)|Projected earnings per share increase next year RGEN|Earnings growth forecast for next year RNA (Avidity Biosciences, Inc.)|CRISPR Therapeutics Inc (CRSP) - Expected net earnings per share growth next year|Sema4 - Earnings growth forecast for next year|Ultragenyx Corp (RARE) - Expected earnings per share growth for next year|BEAM: Earnings growth forecast for next year|sarepta.com - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Twist Bioscience, Inc.|Projected earnings per share growth rate for next year TXG (10x Genomics Inc)|Net earnings per share growth forecast for next year Intellia (NTLA)|STOK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year BioLife Solutions, Inc. BLFS|wavelifesciences.com - Net earnings per share growth forecast for next year|MAZE - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sionna Therapeutics, Inc.|PRME: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Taysha Corp TSHA|Expected earnings per share growth for next year QURE|Expected net earnings per share growth next year meiragtx.com MGTX|Expected earnings per share growth for next year RGNX (REGENXBIO)|Earnings growth forecast for next year Solid Biosciences Inc (SLDB)|Earnings growth forecast for next year OCGN (Ocugen Corp)|PacBio Corp - Net earnings per share growth forecast for next year|BNTC: Expected earnings per share growth for next year|DSGN (designtx.com) - Projected earnings per share growth rate for next year|RCKT: Earnings growth forecast for next year|Projected earnings per share growth rate for next year FDMT|Net earnings per share growth forecast for next year Lexeo Therapeutics Inc.|Projected earnings per share growth rate for next year KRRO (Korro Bio, Inc)|Earnings growth forecast for next year EDIT|Earnings growth forecast for next year silence-therapeutics.com (SLN)|ProQR Therapeutics - Expected earnings per share growth for next year|Earnings growth forecast for next year Codexis Inc CDXS|SGMO - Net earnings per share growth forecast for next year|NAUT (Nautilus Biotechnology) - Projected earnings per share growth rate for next year|MGX: Earnings growth forecast for next year|DTIL - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year GBIO|BOLD (Boundless Bio Inc.) - Projected earnings per share increase next year|Expected earnings per share growth for next year XCUR (Exicure, Inc.)|IMNN - Expected net earnings per share growth next year|Phio Pharmaceuticals Corp. - Expected earnings per share growth for next year|Expected earnings per share trend next year MBIO|TransCode - Earnings growth forecast for next year|BNGO: Net earnings per share growth forecast for next year|APDN: Earnings growth forecast for next year|BLUE - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year ImmunoPrecise Antibodies Ltd|Expected net earnings per share growth next year omegatherapeutics.com OMGA|Expected earnings per share growth for next year OMIC (Singular Genomics)|Projected earnings per share increase next year RGLS|Earnings growth forecast for next year SYRS (Syros)|Telesis Bio, Inc (TBIO) - Expected net earnings per share growth next year|TRACON Pharmaceuticals - Earnings growth forecast for next year
